Growth of Global Healthcare Cold Chain Logistics Market Driven by Increasing Demand for Temperature Sensitive Healthcare Products

The global healthcare cold chain logistics market has grown significantly, owing to the increasing demand for biopharmaceuticals and vaccines. Also, increase in the number of clinical trials, which employ temperature sensitive samples, have stimulated the market growth.



According to IMARC Group’s new report, titled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2018-2023)”, the global healthcare cold chain logistics market reached a value of US$ 10.7 Billion in 2017, growing at a CAGR of 10% during 2010-2017. The growth of market can be attributed to strong sales growth of products requiring cold chain logistics and stricter government regulations regarding efficient storage, handling and transportation of temperature sensitive material. Owing to increasing demand for healthcare cold chain logistics in various segments, the market is expected to reach a value of US$ 16.20 Billion by 2023, growing at a CAGR of 7 % during 2018-2023.

global healthcare cold chain logistics market

Highlights of the global healthcare cold chain logistics market:

  • Vaccines represent the largest sector requiring healthcare cold chain logistics.
  • Cold chain transport services dominated the market, followed by packaging and instrumentation.
  • North America is the largest market for cold chain healthcare logistics.


The need for healthcare cold chain logistics is primarily felt in three major segments: biopharmaceuticals, vaccines and clinical trials. Biopharmaceuticals are generally complex protein molecules and their efficacy requires temperature specific logistics. Any abrupt temperature change may lead to loss of chemical activity and make biopharmaceuticals harmful for human body. Moreover, increasing number of clinical trials employing temperature sensitive materials like blood sample, tissue sample and certain drugs, has stimulated the market growth. Also, demand for vaccines has increased, owing to the mass immunization programmes conducted by various government and non-government organisations. Like biopharmaceuticals, vaccines are also temperature sensitive and their potency may reduce on exposure to temperature variations. Driven by the increasing outsourcing trends in the pharmaceutical and biopharmaceutical industry, the cold chain logistics demand for drugs, vaccines and clinical trial materials is expected to increase significantly.

On the basis of product, vaccines drive the demand for healthcare cold chain logistics market, followed by clinical trials and biopharmaceuticals.  On the basis of segment, transportation accounts for more than half of the global cold chain logistic services. Other major segments are packaging and instrumentation. On the basis of region, North America is the largest market, followed by Asia-Pacific, Europe and others.  Asia-Pacific is the fastest growing region, owing to the developing economies of China, India, South Korea, which are emerging as major destinations for outsourcing clinical trials, drug manufacturing and pathology testing. Some of the key players operating in this market are World Courier, DHL, FedEx, United Parcel Service, Kuehne and Nagel, Cavalier Logistics, DB Schenker, Life ConEx, American Airlines Cargo, Continental Air Cargo and Marken.

The report by IMARC Group has examined the global healthcare cold chain logistics market on the basis of:

Product:

  • Vaccines
  • Clinical trials
  • Biopharmaceuticals


Segment:

  • Transportation
  • Packaging
  • Instrumentation


Region:

  • North America
  • Europe
  • Asia –pacific
  • Rest of the world


Key Players:

  • World Courier
  • DHL
  • FedEx
  • United Parcel Service
  • Kuehne and Nagel
  • Cavalier Logistics
  • DB Schenker
  • Life ConEx
  • American Airlines Cargo
  • Continental Air Cargo
  • Marken.


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal